Pharmacovigilance

Did you know that MedQuímica Pharmacovigilance continuously evaluates the adverse events related to its products?

In compliance with Good Pharmacovigilance Practices, we kindly request your collaboration in reporting any cases of adverse events or technical complaints you become aware of, during or after the use of our products.


What are adverse events?

Any undesirable effects resulting from the use of a medicine, not necessarily having a proven causal relationship.


What are technical complaints?

Any deviations in the quality of medicines that may cause harm to health.


What should be reported?

  • Suspected adverse drug reactions: Any undesirable response suspected to be related to the use of a medication.

  • Therapeutic ineffectiveness, total or partial: When the medicine does not produce the expected result under the conditions of use described in the package insert.

  • Drug interactions: Pharmacological, toxicological, clinical, or laboratory responses caused by the combination of the medicine with other chemical substances, foods, other medications, or diseases.

  • Drug overdose: When the daily maximum dose recommended in the package insert is exceeded.

  • Drug abuse: Excessive and intentional use without medical prescription.

  • Medication errors: Any preventable error related to inappropriate use of a medicine.

  • Off-label use of medicines: When prescribed for indications not approved in the package insert registered with ANVISA.

  • Exposure to medicines during pregnancy/lactation: Use of medicines during pregnancy or breastfeeding.

  • Adverse events due to quality deviation.

  • And other situations that may be subject to Pharmacovigilance.


If you become aware of any of these situations involving our products, please report them below or contact our Customer Service Center (SAC) through 0800 032 4087 / sac@medquimica.com